Consider this illustrative board-style scenario: a quiet 16-year-old whose mother reports “irregular periods” may actually be presenting with a need for confidential pregnancy prevention, STI care, and protection from coercion.
In the scenario, once alone, the patient reports regular cycles, sexual activity, inconsistent condom use, and a desire for highly effective contraception that will not be obvious at home. That change in history is the first discriminating finding: the visit is no longer primarily about abnormal uterine bleeding. It is about creating enough privacy to obtain an accurate history and then offering voluntary, medically appropriate care.
Make privacy part of the clinical examination
Private time should be routine for adolescent visits, not introduced as a punishment for having a controlling parent. A useful script is:
“I spend part of every adolescent visit speaking with the patient alone. We will bring you back together afterward unless there is a serious safety concern.”
Before asking about sex, pregnancy, or substance use, explain the limits of confidentiality. These include imminent risk of self-harm or harm to others, suspected abuse or exploitation, and jurisdiction-specific reporting requirements. The exact rules for consent, parental notification, and reproductive services vary by location.
Confidentiality also has practical failure points. An explanation of benefits, patient portal, shared mobile phone, pharmacy record, or after-visit summary may disclose care even when the method itself is not visible. Therefore, do not promise that contraception can be completely hidden. Ask what communication method is safe, whether the parent monitors devices, and whether using insurance could create danger.
Build the history that supports the formulation
Use HEEADSSS or a similar psychosocial framework, but add a focused reproductive history. Establish menarche, last menstrual period, cycle interval, bleeding duration and volume, dysmenorrhea, pregnancy intention, last unprotected intercourse, sexual practices, partners, condom use, and prior STI testing.
Ask about migraine with aura, personal or family history of venous thromboembolism or known thrombophilia, medications, hypertension, substance use, depression, suicidality, and violence. Ask separately about reproductive coercion: Has a partner ever sabotaged condoms, pressured her to become pregnant, or prevented her from accessing contraception? Also ask whether parental monitoring or punishment could make a chosen method unsafe.
Reframe the “irregular periods” complaint
A menstrual complaint reported by a parent should be verified directly with the adolescent. If her cycles are consistently regular and she denies heavy bleeding, significant pain, or intermenstrual bleeding, there is no confirmed abnormal uterine bleeding diagnosis to make.
| Finding | What it suggests | Reasonable next move |
|---|---|---|
| Regular cycles without pain or heavy bleeding | The stated menstrual problem may reflect family concern rather than disease | Document the patient’s baseline and avoid reflexive testing |
| Missed period or recent unprotected intercourse | Pregnancy must be considered | Obtain pregnancy testing when indicated and assess emergency contraception |
| Persistent infrequent cycles with acne or hirsutism | Anovulation or an endocrine disorder | Perform focused evaluation rather than labeling PCOS from one feature |
| Heavy or prolonged bleeding, bruising, or anemia symptoms | Possible bleeding disorder or other pathology | Consider CBC, ferritin, and targeted evaluation |
| Pelvic pain, discharge, fever, or postcoital bleeding | Infection or another gynecologic process | Examine and test according to symptoms |
The patient’s relaxed demeanor and consistent menstrual history are not diagnostic by themselves, but they are clinically important. They show why the history obtained with the parent present may be unreliable.
Choose contraception without turning LARC into a prescription
An implant or intrauterine device may fit her priorities because both are highly effective and require little ongoing adherence. But “most effective” is not the same as “best for this patient.” Patient choice, informed consent, bleeding expectations, ease of discontinuation, cost, and confidentiality should drive the decision.
| Method | Why it may fit | Important caveats |
|---|---|---|
| Etonogestrel implant | Long-acting, adherence-independent, no pelvic examination for placement | It may be palpable, irregular bleeding is common, and billing may not be private |
| Levonorgestrel IUD | Long-acting and reversible; may reduce heavy bleeding | Insertion requires an examination, strings may be noticed, and it does not prevent STIs |
| Pill, patch, ring, or progestin-only pill | Patient-controlled and easy to stop | Daily or scheduled adherence, packaging, and method-specific contraindications matter |
Before initiating a method, clarify the last menstrual period, recent unprotected sex, pregnancy possibility, and medical eligibility. For routine initiation, if pregnancy cannot be reasonably excluded, do not place an IUD that day; provide an interim plan and reassess. If unprotected intercourse occurred within the previous 5 days, a copper IUD may instead be considered as emergency contraception when clinically eligible. An implant or other non-IUD method can generally be started when uncertainty remains, with a follow-up pregnancy test in 2–4 weeks, if otherwise medically eligible. Offer condoms for STI prevention and make an emergency-contraception plan.
For an estrogen-containing method, counsel the patient to seek urgent evaluation for severe chest pain or shortness of breath, severe abdominal pain, a new severe headache or neurologic symptom, vision changes, or unilateral leg pain or swelling. The familiar ACHES mnemonic can organize this safety-net counseling, but it does not replace screening for migraine with aura, thromboembolic history, hypertension, and other contraindications.
STI screening and HPV vaccination belong in the same visit
Because she is sexually active and younger than 25, she should receive screening for chlamydia and gonorrhea. A vaginal nucleic acid amplification test can be clinician-collected or self-collected, and urine testing may be appropriate depending on the assay. Pharyngeal or rectal testing should be based on reported exposure rather than on assumptions about behavior.
Offer HIV testing at least once and repeat it according to risk. Syphilis testing should be guided by sexual history, local epidemiology, and other risk factors. An asymptomatic adolescent usually does not need a speculum examination simply to obtain STI screening, and cervical cytology is not indicated solely because she is sexually active. A pelvic examination is appropriate when symptoms require it; bimanual examination and cervical inspection are required before IUD placement.
If she has not been adequately vaccinated, offer the 9-valent HPV vaccine now. If the series begins at age 16, use a three-dose schedule at 0, 1–2, and 6 months. The vaccine contains noninfectious virus-like particles made from the L1 major capsid protein and covers HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. Sexual activity is not a reason to withhold vaccination: prior exposure to one type does not imply exposure to all vaccine types, although vaccination does not treat an established infection.
When the mother asks whether her daughter is “clean”
Do not disclose STI results, sexual history, or contraceptive decisions without the patient’s permission unless a specific safety or legal exception applies. A calm response is:
“I discuss private health information with each adolescent individually. I can talk with you about general preventive care, but I cannot share her confidential information without her permission unless safety rules require disclosure.”
Then return to the patient and assess whether the parent’s behavior represents ordinary family conflict, emotional abuse, threats, surveillance, or reproductive coercion. A parent’s anxiety is not itself proof of abuse, and the patient’s request for privacy is not proof of danger. If the adolescent describes abuse, exploitation, trafficking, or imminent harm, explain what must be reported and follow jurisdiction-specific safeguarding and mandatory-reporting procedures.
Common board traps
- Accepting the parent’s chief complaint without verifying it privately.
- Promising that an implant, IUD, or prescription will be completely hidden.
- Presenting LARC as mandatory rather than offering it alongside other methods.
- Forgetting pregnancy assessment, emergency contraception, HIV testing, or exposure-based extragenital testing.
- Assuming HPV vaccination has no value after sexual debut.
- Ordering a routine pelvic examination or Pap test as proof of appropriate STI care.
- Using ACHES as a substitute for method-specific contraindication screening.
Practical takeaways
- Confidential adolescent time is a diagnostic intervention, not an optional courtesy.
- Verify the menstrual complaint directly before labeling abnormal uterine bleeding.
- Match contraception to the patient’s preferences, safety, adherence, bleeding tolerance, and realistic privacy needs.
- Pair pregnancy prevention with condoms, STI screening, emergency contraception planning, and HIV risk assessment.
- Offer catch-up HPV vaccination at the same visit if she is not adequately vaccinated; sexual activity does not eliminate its preventive value.
- Document what confidentiality means in the local setting, including portal, billing, pharmacy, and mandatory-reporting limitations.